Objective: To investigate the effects of 7,8-dihydroxy coumarin on the chondrogenic differentiation of rat adipose-derived mesenchymal stem cells (ADMSCs). Methods: ADMSCs were cultured using a micromass suspension method and incubated with different concentrations of 7,8-dihydroxy coumarin and transforming growth factor (TGF)-b 1 for 3 weeks: group A (negative control, no drug treatment); group B (positive control, 10 ng/ml TGFb 1 ); groups C, D and E (incubated with 25, 50 and 100 mg/ml 7,8-dihydroxy coumarin, respectively); groups F, G and H (incubated with 25, 50 and 100 mg/ml 7,8-dihydroxy coumarin, respectively, plus 10 ng/ml TGF-b 1 ). Markers of chondrogenic differentiation were measured using histology, immunohistochemistry, enzyme-linked immunosorbent assay and reverse transcriptionpolymerase chain reaction. Results: When used alone, 7,8-dihydroxy coumarin only weakly induced the chondrogenic differentiation of ADMSCs. 7,8-Dihydroxy coumarin used in combination with TGF-b 1 strongly induced chondrogenic differentiation of ADMSCs. For some of the markers of chondrogenic differentiation, the extent of the induction was 7,8-dihydroxy coumarin dose-dependent. Conclusions: 7,8-Dihydroxy coumarin appears to work synergistically with TGF-b 1 to strongly induce chondrogenic differentiation of rat-derived ADMSCs.
Introduction
Degeneration of articular cartilage and bone defects caused by trauma and chronic bone joint diseases are common problems. It is difficult to repair damaged articular cartilage because it receives no nourishment from blood vessels and surrounding tissue, and transplanted chondrocytes have very limited proliferative abilities. 1 Clinical treatments for repairing cartilage damage include arthroscopic lavage debridement, subchondral bone drilling, microfracture technology, periosteum or perichondrium transplantation, and autologous or allogeneic bone and cartilage transplantation. 2 These treatments either have a poor prognosis or are unable to restore all of the normal biomechanical characteristics fully, in damaged articular cartilage. 2 Tissue engineering applies biological substitutes in order to repair damaged tissues. 2 The autologous chondrocyte is the only cartilage seed cell that has been applied clinically for tissue engineering, 3 but there are a number of limitations associated with its use: the donor source is limited; chondrocyte isolation and in vitro culture are difficult; autologous chondrocytes have a poor proliferative capacity. [4] [5] [6] Alternative sources of cells would be embryonic stem cells and induced pluripotent stem cells but, because of ethical and safety issues, their use remains a long way from clinical application. 7, 8 Adult stem cells are widely distributed throughout the body, especially adipose-derived mesenchymal stem cells (ADMSCs), which are readily available and easily obtained, making them ideal candidates for use as tissue-engineered seed cells for tissue repair. [9] [10] [11] Rapid amplification of a large number of stem cells in vitro and more efficient induction of differentiation towards chondrocytes remain the most important issues to be addressed in this research field. 12, 13 Currently, the cytokines and chemokines used for chondrocyte cell culture are very expensive, and simulating the multiple factors that are required to induce chondrocyte differentiation in vitro is difficult. There is a growing interest in the ability of traditional medicines, often derived from plants, to promote osteogenesis. [14] [15] [16] [17] [18] [19] [20] Studies have shown that 7,8-dihydroxy coumarin (also known as daphentin), which is obtained from the fruits and seeds of several plants including Daphne mezereum (commonly known as mezereon), can promote bone formation and increase bone mineral density. 21 , 22 Tang et al. 21 reported that coumarin and its derivatives can activate the p38-and extracellular signal-regulated proteindependent signalling pathways in rat osteoblasts, increase bone morphogenic protein-2 (BMP-2) mRNA levels and promote bone formation. Another study reported that the coumarin-like derivative osthole (also known as 7-methoxy-8-isopentenoxycoumarin), which can be purified from Cnidium monnieri and Angelica pubescens plants, was able to activate the Wnt/bcatenin-BMP-2 signalling pathways in mouse osteoblasts, promote osteoblast differentiation, contribute substantially to mouse skull bone repair and increase bone mineral density. 22 The present study investigated the ability of 7,8-dihydroxy coumarin to induce the chondrogenic differentiation of rat-derived ADMSCs compared with transforming growth factor (TGF)-b 1 , which-as a known inducer of chondrogenic differentiation of ADMSCs-was used a positive control. 10 
Materials and methods Animals
This study was conducted at the College of Pharmacy of Jilin University, Changchun, Jilin Province, China. Male SpragueDawley rats, aged 6-8 weeks with a body weight of 221 AE 30 g, were provided by the Experimental Animal Centre of Jilin University (Changchun, Jilin Province, China). The animals were housed under a 12-h light/12-h dark cycle and allowed free access to food and water.
In the absence of a local Animal Ethics Committee at Jilin University, the study protocol was supported by the College of Pharmacy, Jilin University. All animal feeding, care and experimental testing complied with the guidelines for animal use and care, produced by Jilin University Animal Care and Welfare Committee. Other than the individual reagents specified in detail in the sections below, all other laboratory grade reagents were sourced from within China.
Isolation of Rat-derived ADMSCs and Drug Treatment
A total of 20 rats were sacrificed by neck dislocation, followed by 75% ethanol disinfection. A sample of fat tissue (1 g) was taken from the groin and subrenal area, and washed three times with Dulbecco's Modified Eagle's Medium (DMEM)/F12 medium (GIBCO Õ Cell Culture, Carlsbad, CA, USA) supplemented with 100 IU/ml each of penicillin and streptomycin (North China Pharmaceutical Company, Shijiachuang, China) and 10% fetal bovine serum (FBS; GIBCO Õ Cell Culture). Visible blood vessels and other tissues were removed from the fat sample, followed by repeated washing with 200 mM phosphatebuffered saline (PBS; pH 7.0) at 37 C. The fat tissues were cut into 1-mm 3 pieces, placed in 0.1% type I collagenase solution (SigmaAldrich, St Louis, MO, USA) and incubated at 37 C for 60 min. The digested cells were filtered using a 75 -mm mesh sieve (Xiamen Jingfeng Nylon Netting Company, Xiamen, China), followed by washing with 200 mM PBS (pH 7.0) at 37 C and centrifuged at 260 g to remove the type I collagenase. The cells were cultured in DMEM/F12 medium containing 10% FBS at 37 C with 5% CO 2 , in a humidified atmosphere.
Rat ADMSCs were cultured using a micromass suspension method as follows. Rat ADMSCs that were between the third and fifth passage were digested using 0.25% trypsin solution (Sigma-Aldrich), resuspended, counted and adjusted to a final density of 10 7 cells/ml. Cells (20 ml of cell suspension) were seeded onto the inner wall of the cover of 24-well plates (Costar Õ , Sigma-Aldrich) and incubated overnight at 37 C with 5% CO 2 in a humidified atmosphere. After 14 h, a cell mass was formed and moved from the wall into the well of the 24-well plate, and 1 ml of DMEM/F12 medium containing 10% FBS was added to the well. At the same time, the experimental drugs were added to induce stem-cell differentiation. The experimental drugs, 7,8-dihydroxy coumarin (Sigma-Aldrich) and TGF-b 1 (Sigma-Aldrich), were dissolved in 200 mM PBS (pH 7.0) prior to use.
The experiments were performed in eight groups, with each group consisting of three wells: group A: negative control, no experimental drug; group B: positive control, 10 ng/ml TGF-b1; groups C, D and E, treated with 25, 50 and 100 mg/ml 7,8-dihydroxy coumarin, respectively; groups F, G and H, treated with 25, 50 and 100 mg/ml 7,8-dihydroxy coumarin, respectively, plus10 ng/ml TGF-b 1 . The cell-culture medium was changed every 3 days, accompanied by supplementation of the working concentration of the experimental drug(s). Each time the medium was changed, the cell mass was gently pushed up into suspension from the bottom of the plate. The induction of differentiation phase lasted 3 weeks.
Alcian Blue and Periodic Acid-Schiff Staining
After 3 weeks' treatment, the cell mass from the cell culture well was fixed in 10% neutral-buffered formalin solution for 24 h, then subjected to ethanol gradient dehydration and embedding in paraffin wax. Sections (5 mm thick) were cut from the specimens, mounted onto glass slides, then dewaxed and washed with deionized water. Sections were treated consecutively with 3% acetic acid for 1 min, 1% alcian blue solution (Wuhan Boster Biological Technology, Wuhan, Hubei, China) for 15 min, deionized water for 3 min, 1% periodic acid (Wuhan Boster Biological Technology) for 10 min, deionized water for 3 min, Schiff Reagent (Wuhan Boster Biological Technology) for 15 min and deionized water for 3 min. For staining with alcian blue alone, sections were treated consecutively with 3% acetic acid for 1 min and 1% alcian blue solution for 15 min. The specimens were subjected to gradient alcohol dehydration and xylene, and were mounted with neutral gum for light microscopy. Alcian blue was used alone to stain acid mucopolysaccharides (stained blue) and the combination of alcian blue and periodic acid-Schiff was used to stain both acid (stained blue) and neutral mucopolysaccharides (stained magenta).
Immunohistochemical Staining to Detect Type II Collagen
Dewaxed slices of cell mass were prepared as described above, then incubated in 3% hydrogen peroxide at room temperature for 10 min and washed three times with 200 mM PBS (pH 7.0). For antigen retrieval, specimens were incubated in 1.0 mM ethylenediaminetetra-acetic acid (EDTA; pH 9.0) in a boiling-water bath for 2 h, and incubated with 10% horse serum (HyClone, Beijing, China) at room temperature for 10 min to block endogenous nonspecific antigens. Mouse antirat type II collagen monoclonal antibody (1 : 1000 dilution; Santa Cruz Biotechnology, Santa Cruz, CA, USA) was added to the slides and incubated overnight at 4 C. After washing three times with 200 mM PBS (pH 7.0), biotinylated goat antimouse polyclonal secondary antibody (1 : 5000 dilution; Santa Cruz Biotechnology) was added and incubated at room temperature for 30 min. The specimens were washed three times with 200 mM PBS (pH 7.0), incubated with streptavidin-alkaline phosphatase (1 : 10,000 dilution; Invitrogen, Beijing, China) at room temperature for 30 min, washed three times with 200 mM PBS (pH 7.0), and incubated with 3,3 0 -diaminobenzidine (DAB) substrate (0.05% diluted in 200 mM PBS, pH 7.0) for 5 min at room temperature. The slides were washed gently using deionized water, which was rinsed slowly down the back of the slide, followed by dehydration through a graded series of alcohol and xylene, and then mounted with neutral gum for light microscopy.
ELISA to Detect GAG Content
Enzyme-linked immunosorbent assay (ELISA) analysis was used to assess the secretion of glycosaminoglycans (GAG) by the cell masses into the cell culture supernatant. After 3 weeks' treatment, cell-culture supernatants were centrifuged at 314 g for 10 min. An ELILSA kit for GAG (alcian blue method; Wuhan Boster Biological Technology) was used according to the manufacturer's instructions and the absorbance was measured at 490 nm. The GAG content secreted into the supernatant was determined according to the standard curve for a preparation of standard GAG that was provided with the kit. The minimum detectable concentration of GAG was 10.0 ng/ml. Intraand interassay coefficients of variation for the ELISA were 3% and 5%, respectively.
RT-PCR
After 3 weeks' treatment, the cell mass was collected from the cell-culture well and transferred into an Eppendorf tube containing 500 ml of 1 mg/ml proteinase K (Sigma-Aldrich) for digestion at 56 C for 1 h, followed by centrifugation at 260 g for 5 min. The pellets were dissolved in 1 ml of TRIzol Ltd), and mixed with an equal volume of isopropanol at room temperature for 15 min, followed by centrifugation at 4 C, 20,000 g for 20 min. The pellets were washed with 1 ml of 75% ethanol/ DEPC-treated water, followed by centrifugation at 4 C, 20,000 g for 10 min. The pellets were air dried to obtain the RNA, followed by the addition of 20 ml of DEPC-treated water. RNA purity and concentration were determined using an ultraviolet (UV) spectrophotometer to measure the optical density (OD) 260/ OD280 absorbance values of a 100-fold dilution in 1.0 M Tris-EDTA buffer (pH 9.0).
For the reverse transcription-polymerase chain reaction (RT-PCR), DNase I (Takara Biotechnology) was added to remove the genomic DNA. The cDNA was synthesized using an RT kit (Takara Biotechnology ) . PCR products were separated on 1.5% agarose gel (containing 0.5 mg/ml ethidium bromide), with an electrophoresis sample volume of 5 ml. The PCR products were visualized by scanning the agarose gel using a UVP gel imaging analysis system (UVP, Upland, CA, USA), followed by a semiquantitative analysis by calculating the target genes versus b-actin (internal control) grey-scale ratio, using the same UVP gel imaging analysis system.
Statistical Analyses
All statistical analyses were performed using the SPSS Õ statistical software package, version 12.0 (SPSS Inc., Chicago, IL, USA) for Windows Õ . Mean values of the GAG concentrations were compared using Student's t-test and a P-value < 0.05 was considered to be statistically significant.
Results
Histological staining of the sections of ADMSC cell mass using alcian blue showed that the negative control sample ( Figure 1A) , compared with the positive control cells treated with TGF-b 1 alone ( Figure. 1B) , demonstrated a reduced level of acid mucopolysaccharides, similar to the levels in the three groups that were treated with 7,8-dihydroxy coumarin alone ( Figures  1C-E) . Cells treated with both 7,8-dihydroxy coumarin and TGF-b 1 ( Figures  1F-H) were more intensely stained than the negative control sample ( Figure 1A) , especially the cells treated with 50 and 100 mg/ml 7,8-dihydroxy coumarin ( Figures  1G and H) .
Histological staining of the sections of ADMSC cell mass using alcian blue and periodic acid-Schiff to stain for both acid (blue stained) and neutral (magenta stained) mucopolysaccharides showed that there were low levels of acid mucopolysaccharides and high levels of neutral mucopolysaccharides in the negative control cells (Figure 2A positive for neutral mucopolysaccharides ( Figures 2F-H) .
Immunohistochemical staining of sections of ADMSC cell mass for type II collagen showed no staining in the negative control cells ( Figure 3A ) compared with the positive control cells treated with TGF-b 1 alone (Figure 3B ), which were stained positive for type II collagen protein. Cells treated with 7,8-dihydroxy coumarin alone were very weakly positive compared with the negative control (25 and 50 mg/ml groups; Figures 3C and D) or only had very low levels of staining for type II collagen (100 mg/ ml group; Figure 3E ). Cells treated with both 7,8-dihydroxy coumarin and TGF-b 1 demonstrated increased levels of type II collagen ( Figures 3F-H) , compared with both the negative control cells ( Figure 3A ) and the TGF-b 1 -treated positive control cells ( Figure 3B) .
The ELISA analysis demonstrated that treatment of the ADMSC cell masses for 3 weeks with TGF-b 1 alone (group B) or with 7,8-dihydroxy coumarin alone (groups C, D and E) significantly increased the levels of GAG measured in the cell culture supernatant, compared with the negative control group (group A) (P < 0.001 for all comparisons) ( Table 2 ). The combination treatment of 7,8-dihydroxy coumarin and TGF-b 1 for 3 weeks (groups F, G and H) significantly increased levels of GAG in the cell culture supernatant, compared with both the negative and positive control groups (groups A and B, respectively) (P < 0.001 for all comparisons).
The effects of 3 weeks' treatment of the ADMSC cell masses with 7,8-dihydroxy coumarin, with or without TGF-b 1 , on the mRNA levels of three chondrogenic genes (PGC1-, SOX9, and COL2A1) are shown in 
Discussion
It would be extremely beneficial if a naturally occurring agent could be identified that could induce ADMSCs to undergo chondrogenic differentiation, as it might be expected to help these cells to repair injured cartilage. The present study used routine histological staining (with alcian blue alone and in combination with periodic acidSchiff) to identify acid and neutral mucopolysaccharides, immunohistochemical staining of type II collagen protein, an ELISA (to measure GAG secretion) and RT-PCR (to detect chondrogenic differentiation-related mRNA levels), in order to measure the extent of chondrogenic differentiation in rat ADMSCs treated with 7,8-dihydroxy coumarin (with or without TGF-b 1 ) for 3 weeks in cell culture. When used alone, 7,8-dihydroxy coumarin was only a weak inducer of chondrogenic differentiation of rat ADMSCs, but the findings suggested that it synergized with TGF-b 1 to more strongly promote the chondrogenic differentiation above that achieved by TGF-b 1 treatment alone. The present study used the micromass suspension method to culture rat ADMSCs; this method has been shown to facilitate cell aggregation and chondrogenic differentiation. 23 The chondrogenic differentiation markers used in the current study included two components: the production of extracellular matrix proteins (i.e. type II collagen, acid and neutral mucopolysaccharides and GAG) and the expression of chondrogenic differentiation-related genes. 10 The present study demonstrated markers indicating chondrogenic differentiation in the ADMSC cell mass and the secretion of GAG into the culture supernatant, suggesting that this culture system was able to support chondrogenic differentiation.
Coumarin is cytotoxic to human peripheral blood mononuclear cells and bone marrow progenitor stem cells; 24 there is no toxicity for doses up to 100 mg/ml, but higher doses (up to 200 mg/ml) have obvious inhibitory effects. The present study used 7,8-dihydroxy coumarin at three concentrations (25, 50 and 100 mg/ml) that are within the range associated with better safety. Treatment of rat ADMSC cell masses with those three doses of 7,8-dihydroxy coumarin was only a weak inducer of chondrogenic differentiation. Levels of GAG that were secreted were low; cells synthesized predominantly neutral rather than acid mucopolysaccharides, and produced very low levels of type II collagen protein. In terms of inducing expression of three chondrogenic differentiation-related genes, PGC1-a, SOX9 and COL2A1 mRNA levels in ADMSC cell masses treated with the three doses of 7,8-dihydroxy coumarin were identical to the levels observed with negative control cells (treated with neither of the two experimental drugs). These findings suggested that the doses of 7,8-dihydroxy coumarin were insufficient to induce chondrogenic differentiation, or that 7,8-dihydroxy coumarin might not induce the expression of genes involved in chondrogenic differentiation, in rat ADMSCs. When used alone, TGF-b 1 (10 ng/ml) was able to induce chondrogenic differentiation, as demonstrated by increased levels of GAG secreted into the supernatant, the production of predominantly acid (rather than neutral) mucopolysaccharides, and the production of increased levels of type II collagen protein. TGF-b 1 treatment also upregulated the levels of PGC1-a, SOX9 and COL2A1 mRNA, which can be considered indicative of chondrogenic differentiation.
When 7,8-dihydroxy coumarin and TGFb 1 were used in combination, the effect on the induction of chondrogenic differentiation of ADMSCs increased markedly in a dose-dependent manner, based on the dose of 7,8-dihydroxy coumarin. This was particularly evident in terms of the secretion of GAG into the cell-culture supernatant and the results of the RT-PCR analyses undertaken for the levels of chondrogenic gene expression. PGC-1a, a member of a family of transcription coactivators, plays a key role in cellular energy metabolism. 25 As part of its role as a transcriptional activator, PGC-1a can combine with the transcription factor SOX9 to regulate expression of the cartilage-specific gene COL2A1, 26 thereby regulating cartilage formation. The present study showed that the combination of 7,8-dihydroxy coumarin and TGF-b 1 upregulated PGC-1a, with treatment with the three concentrations of 7,8-dihydroxy coumarin resulting in similar levels of PGC-1a mRNA, which were 1.5-fold higher than the level seen with TGF-b 1 alone. SOX9 is also one of the key transcription factors for cartilage formation.
27 SOX9 can regulate the cartilage-specific genes that encode for collagen type II and BMP-2, promoting cartilage formation. 27 The present study showed that 7,8-dihydroxy coumarin and TGF-b 1 upregulated SOX9 in a dosedependent manner, based on the 7,8-dihydroxy coumarin dose (25, 50 and 100 mg/ml). COL2A1 is a cartilage-specific gene that encodes the type II collagen a-1 chain and is a cartilage-specific marker.
26 COL2A1 mRNA was also upregulated in a dosedependent manner, based on the 7,8-dihydroxy coumarin dose (25, 50 and 100 mg/ml) in the present study. Upregulation of mRNA levels of these three genes demonstrated that the ADMSCs had differentiated (or were in the process of differentiating) into cartilage, as a result of treatment with 7,8-dihydroxy coumarin and TGF-b 1 .
Studies have shown that the coumarin used alone can promote the growth of osteoblasts and bone formation in mice. 21, 22 The present study found that 7,8-dihydroxy coumarin (used alone) lacked the ability to induce strongly the chondrogenic differentiation of rat ADMSCs, which suggests that osteoblasts and ADMSCs might have important differences. Osteoblasts are destined to form bones, whereas ADMSCs are pluripotent stem cells. When exposed to coumarin, osteoblasts grow and ultimately form bone tissue. In contrast, ADMSCs differentiate into chondroblasts, which then form cartilage. These contrasting findings suggest that coumarin may be able to promote bone formation strongly by inducing the differentiation of osteoblasts, but that its actions are limited in terms of being able to promote the differentiation of pluripotent stem cells into chondroblasts.
Some studies have reported the opposite effects for coumarin. For example, a histological study found that the anticoagulants heparin and coumarin reduced the number of cells of the epiphyseal cartilage in mice. 28 A possible explanation for this is that the two anticoagulants were used at doses that were cytotoxic, causing inhibition of cell proliferation, which would have adversely affected cartilage formation. Another study reported that heparin and coumarin reduced bone density. 29 Coumarin is used as an anticoagulant thrombolytic agent, and the clinical dose is usually well above the safe range of 100 mg/ml. Thus, the clinical use of coumarin may inhibit bone formation by osteoblasts, causing a decrease in bone mineral density.
In conclusion, 7,8-dihydroxy coumarin used alone was a weak inducer of the chondrogenic differentiation of rat ADMSCs, but was able to synergize with TGF-b 1 to induce chondrogenic differentiation strongly, with the 50 and 100 mg/ml doses being particularly effective at inducing GAG secretion, type II collagen deposition and upregulation of three chondrogenic differentiation-related mRNAs.
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